How I treat POEMS syndrome
Open Access
- 14 June 2012
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 119 (24) , 5650-5658
Abstract
POEMS syndrome is a paraneoplastic syndrome whose acronym stands for less than half of the defining features of the disease, that is, polyradiculoneuropathy, organomegaly, potentially including coexisting Castleman disease, endocrinopathy, monoclonal plasma cell neoplasm, and skin changes. The other important features include papilledema, extravascular volume overload, sclerotic bone lesions, thrombocytosis, elevated VEGF, and abnormal pulmonary function. The diagnosis is based on having both the polyradiculoneuropathy and the monoclonal plasma cell disorder, and at least 1 of the other 3 major criteria (Castleman disease, sclerotic bone lesions, or elevated VEGF) and at least one minor criterion. The diagnosis is often delayed with intervening incorrect diagnoses of chronic inflammatory demyelinating polyradiculoneuropathy, myeloproliferative disorder, and monoclonal gammopathy of undetermined significance. Prompt treatment directed at the underlying plasma cell clone produces dramatic responses in the majority of patients. Although there are no randomized clinical trial data to direct best therapy, for patients with disseminated disease, high-dose chemotherapy with peripheral blood transplantation has yielded durable benefit, whereas radiation therapy is typically effective for patients with a more localized presentation. More universal recognition of and more scientific inquiry into the underpinnings of the disease will provide direction toward the best treatment strategies in the future.Keywords
This publication has 94 references indexed in Scilit:
- Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDPJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathyJournal of Neurology, Neurosurgery & Psychiatry, 2012
- POEMS syndrome with severe neurological damage clinically recovered with lenalidomideHaematologica, 2011
- Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndromeBlood, 2011
- Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patientsBlood, 2011
- Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndromeAmerican Journal of Hematology, 2010
- Calciphylaxis as a Catastrophic Complication in a Patient with POEMS SyndromeCase Reports in Neurology, 2009
- Cerebral infarction in POEMS syndromeNeurology, 2009
- Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeEuropean Journal of Haematology, 2008
- Endocrinopathy in POEMS Syndrome: The Mayo Clinic ExperienceMayo Clinic Proceedings, 2007